These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 14558414)

  • 1. [Levofloxacin (Tavanic) in the treatment of corneal ulcers].
    Maĭchuk IuF
    Antibiot Khimioter; 2003; 48(6):16-9. PubMed ID: 14558414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double-masked, randomized, controlled trial with conventional dual therapy. The Ofloxacin Study Group.
    Ophthalmology; 1997 Nov; 104(11):1902-9. PubMed ID: 9373124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lomefloxacin in treatment of infectious eye diseases].
    Maĭchuk IuF; Vakhova ES; Kononenko LA
    Antibiot Khimioter; 1998; 43(10):32-5. PubMed ID: 9825108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo.
    Caballero AR; Marquart ME; O'Callaghan RJ; Thibodeaux BA; Johnston KH; Dajcs JJ
    Curr Eye Res; 2006 Jan; 31(1):23-9. PubMed ID: 16421016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of topical lomefloxacin 0.3 per cent versus topical ciprofloxacin 0.3 per cent for the treatment of presumed bacterial corneal ulcers.
    Booranapong W; Kosrirukvongs P; Prabhasawat P; Srivannaboon S; Suttiprakarn P
    J Med Assoc Thai; 2004 Mar; 87(3):246-54. PubMed ID: 15117040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis.
    Schwab IR; Friedlaender M; McCulley J; Lichtenstein SJ; Moran CT;
    Ophthalmology; 2003 Mar; 110(3):457-65. PubMed ID: 12623805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciprofloxacin, lomefloxacin, or levofloxacin as treatment for chronic osteomyelitis.
    Greenberg RN; Newman MT; Shariaty S; Pectol RW
    Antimicrob Agents Chemother; 2000 Jan; 44(1):164-6. PubMed ID: 10602739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of acute bacterial conjunctivitis with topical lomefloxacin 0.3% compared to topical ofloxacin 0.3%.
    Tabbara KF; El-Sheikh HF; Islam SM; Hammouda E
    Eur J Ophthalmol; 1999; 9(4):269-75. PubMed ID: 10651190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of experimental bacterial keratitis with topical trovafloxacin.
    Barequet IS; Denton P; Osterhout GJ; Tuli S; O'Brien TP
    Arch Ophthalmol; 2004 Jan; 122(1):65-9. PubMed ID: 14718297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ocular penetration of levofloxacin 1.5% and gatifloxacin 0.3% ophthalmic solutions in subjects undergoing corneal transplant surgery.
    Holland EJ; McCarthy M; Holland S
    Curr Med Res Opin; 2007 Dec; 23(12):2955-60. PubMed ID: 17939882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sparfloxacin and levofloxacin.
    Med Lett Drugs Ther; 1997 Apr; 39(999):41-3. PubMed ID: 9137295
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis.
    Panda A; Ahuja R; Sastry SS
    Eye (Lond); 1999 Dec; 13 ( Pt 6)():744-7. PubMed ID: 10707137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis.
    Dajcs JJ; Thibodeaux BA; Marquart ME; Girgis DO; Traidej M; O'Callaghan RJ
    Antimicrob Agents Chemother; 2004 Jun; 48(6):1948-52. PubMed ID: 15155183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of topical 0.3% ofloxacin to fortified tobramycin-cefazolin in the therapy of bacterial keratitis.
    Khokhar S; Sindhu N; Mirdha BR
    Infection; 2000; 28(3):149-52. PubMed ID: 10879638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharma-clinics. The drug of the month. Levofloxacin (Tavanic)].
    Scheen AJ
    Rev Med Liege; 2000 Nov; 55(11):1015-7. PubMed ID: 11195704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A controlled trial of levofloxacin and lomefloxacin in the treatment of complicated urinary tract infection.
    Klimberg IW; Cox CE; Fowler CL; King W; Kim SS; Callery-D'Amico S
    Urology; 1998 Apr; 51(4):610-5. PubMed ID: 9586615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of ophthalmic gatifloxacin 0.3% and ciprofloxacin 0.3% in healing of corneal ulcers associated with Pseudomonas aeruginosa-induced ulcerative keratitis in rabbits.
    Jensen H; Zerouala C; Carrier M; Short B
    J Ocul Pharmacol Ther; 2005 Feb; 21(1):36-43. PubMed ID: 15718826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic efficacy of ophthalmic quinolones in experimental endophthalmitis in rabbits.
    Wada T; Kozai S; Tajika T; Sakaki H; Suzuki T; Ohashi Y
    J Ocul Pharmacol Ther; 2008 Jun; 24(3):278-89. PubMed ID: 18462067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of lomefloxacin in treatment of nonspecific inflammatory diseases and in prophylaxis of postoperative complications in urology].
    Derevianko II; Khodyreva LA; Avdoshin VL; Andriukhin MI; Gabliia MIu
    Antibiot Khimioter; 1998; 43(10):36-41. PubMed ID: 9825109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of lomefloxacin and ofloxacin in complex therapy of infections in patients with burns].
    Krutikov MG; Alekseev AA; Bobrovnikov AE; Grishina IA; Elagina LV; Izotova GN; Iakovlev VP
    Antibiot Khimioter; 1998; 43(10):27-31. PubMed ID: 9825107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.